Insider screener

Period: 12 months Type of trade: Sold × Plan: Discretionary × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,351 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,351 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,351 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,351 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,351 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,351 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,351 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
25 Nov 2025
Zine Mazouzi Chief Financial Officer
Sold at will
$526.48K 12,473 at 42.21
16.1%
Not planned
25 Nov 2025
Michael O McCarthy III Chief Legal Officer · indirect
Sold at will
$471.65K 40,000 at 11.79
22.5%
Not planned
25 Nov 2025
Brian K Miller Executive VP and CFO
Sold at will
$469.08K 1,000 at 469.08
7.3%
Not planned
25 Nov 2025
Clinton Larry Stinchcomb President and CEO
Sold at will
$462.40K 100,000 at 4.62
4.0%
Not planned
25 Nov 2025
Sold at will
$459.96K 4,234 at 108.64
9.2%
Not planned
25 Nov 2025
Daniel Woolson VP, GM-Infusion Capital
Sold at will
$441.36K 2,897 at 152.35
20.4%
Not planned
25 Nov 2025
Anil P. Ranganath See remarks
Sold at will
$435.66K 3,000 at 145.22
17.7%
Not planned
25 Nov 2025
W Kirk Wycoff Director
Sold at will
$407.40K 22,558 at 18.06
1.1%
Not planned
25 Nov 2025
Erin L Russell Director
Sold at will
$405.18K 1,435 at 282.36
31.9%
Not planned
25 Nov 2025
Curt Calaway Chief Financial Officer
Sold at will
$373.97K 6,539 at 57.19
17.0%
Not planned
25 Nov 2025
Andrew L. Vitus Director · indirect
Sold at will
$371.90K 5,982 at 62.17
54.1%
Sold half or more
25 Nov 2025
William Guyer Chief Development Officer
Sold at will
$364.07K 4,500 at 80.90
85.1%
Sold half or more
25 Nov 2025
David H. Sampsell VP, Corp. Dev, GC & Corp. Sec.
Sold at will
$363.24K 8,748 at 41.52
0.0%
Not planned
25 Nov 2025
Kimberly S Cuccia EVP, GC & Corporate Secretary
Sold at will
$345.04K 8,000 at 43.13
16.2%
Not planned
25 Nov 2025
Oliver K. Mihm Exec VP & COO
Sold at will
$333.18K 2,327 at 143.18
11.2%
Not planned
25 Nov 2025
Peter Otteni V Executive Vice President
Sold at will
$300.47K 4,136 at 72.65
100%
Sold half or more
25 Nov 2025
Michael Craig Price SVP & Pres Off-Highway Drive
Sold at will 11×
$298.48K 13,300 at 22.44
49.7%
Not planned
25 Nov 2025
Ezra M Friedberg Director · indirect
Sold at will 4×
$280.28K 10,000 at 28.03
25.0%
Not planned
25 Nov 2025
Roxanne Oulman Director
Sold at will
$277.96K 1,800 at 154.42
31.8%
Not planned
25 Nov 2025
Kimberly Alexy Director
Sold at will
$272.27K 1,768 at 154.00
33.0%
Not planned
25 Nov 2025
Jed Milstein SVP & CHRO
Sold at will
$266.31K 1,132 at 235.26
10.0%
Not planned
25 Nov 2025
Felitia Lee Controller and CAO
Sold at will 2×
$263.28K 873 at 301.58
11.8%
Not planned
25 Nov 2025
Ryan F Raber EVP - Strategy, Sales & Mktg
Sold at will 2×
$250.19K 15,000 at 16.68
14.1%
Not planned
25 Nov 2025
Vicky B Gregg Director
Sold at will
$239.70K 1,250 at 191.76
6.8%
Not planned
25 Nov 2025
Sold at will
$239.68K 5,160 at 46.45
33.7%
Not planned
25 Nov 2025
Alice Christenson Chief Accounting Officer
Sold at will
$229.57K 1,323 at 173.52
52.3%
Sold half or more
25 Nov 2025
Lance A Soliday SVP & Chief Accounting Officer
Sold at will
$219.93K 856 at 256.93
7.3%
Not planned
25 Nov 2025
Eric Shroff Senior Vice President
Sold at will
$203.04K 1,586 at 128.02
5.0%
Not planned
25 Nov 2025
Sven Wehrwein Director
Sold at will
$188.75K 4,967 at 38.00
12.6%
Not planned
25 Nov 2025
John E Byom Director
Sold at will
$178.05K 3,000 at 59.35
5.5%
Not planned
25 Nov 2025
Terrence G. Schneider VP, Supply Chain
Sold at will
$175.39K 4,208 at 41.68
14.5%
Not planned
25 Nov 2025
Simon Wilson CEO, Markel Insurance
Sold at will
$155.47K 75 at 2,072.94
4.1%
Not planned
25 Nov 2025
Sold at will
$143.90K 10,000 at 14.39
5.6%
Not planned
25 Nov 2025
Rory J. Cutaia Director
Sold at will
$130.54K 42,800 at 3.05
5.4%
Not planned
25 Nov 2025
Peter Migliorini Director
Sold at will
$126.43K 3,000 at 42.14
14.4%
Not planned
25 Nov 2025
Howard W Robin President & CEO
Sold at will
$119.80K 2,207 at 54.28
3.9%
Not planned
25 Nov 2025
Scott C Wylie Chairman, CEO and President
Sold at will
$117.75K 5,000 at 23.55
0.7%
Not planned
25 Nov 2025
Richard K Prins Director
Sold at will
$113.25K 4,179 at 27.10
10.6%
Not planned
25 Nov 2025
Kenneth J Widder Director
Sold at will
$111.97K 4,026 at 27.81
9.8%
Not planned
25 Nov 2025
Lisa Keith EVP, Gen. Counsel, Secretary
Sold at will
$105.13K 2,500 at 42.05
8.8%
Not planned
25 Nov 2025
Stanley Hills LLC 10% owner
Sold at will
$104.00K 10,000 at 10.40
0.3%
Not planned
25 Nov 2025
Prashant Ranade Director
Sold at will
$97.27K 637 at 152.70
5.9%
Not planned
25 Nov 2025
Sold at will
$90.08K 4,500 at 20.02
25.1%
Not planned
25 Nov 2025
Sold at will
$89.70K 100 at 896.97
19.0%
Not planned
25 Nov 2025
Mark A Maples Vice President of Subsidiary
Sold at will
$86.90K 1,450 at 59.93
100%
Sold half or more
25 Nov 2025
Sold at will
$81.33K 3,000 at 27.11
75.0%
Sold half or more
25 Nov 2025
Keith E. Bornemann Chief Accounting Officer
Sold at will
$77.00K 2,200 at 35.00
20.2%
Not planned
25 Nov 2025
Dongfang Liu Chief Medical Officer
Sold at will
$75.00K 10,000 at 7.50
35.7%
Not planned
25 Nov 2025
Sold at will
$69.93K 269 at 259.97
4.8%
Not planned
25 Nov 2025
Glenn H Nussdorf Director
Sold at will
$63.83K 12,043 at 5.30
0.4%
Not planned
Showing 21,751–21,800 of 23,351. ← Newer Page 436 of 468 Older →